Article information
Abstract
The present article is an update of the literature on invasive fungal infections caused by filamentous fungi in critically ill patients. A multidisciplinary group of Spanish physicians with an interest in these infections organized a joint session and selected the most important papers produced lately in the field. Each article was analyzed and discussed by one of the members of the panel. Studies from the fields of causative microorganisms, epidemiology, and diagnosis are discussed; including the assessment of different strategies for the early identification and treatment of patients at risk of fungal infections by filamentous fungi in the intensive care unit setting.
Keywords:
Invasive fungal infection
ICU
Moulds
Aspergillus
COPD
Resumen
El presente trabajo es una revisión de la bibliografía más relevante publicada recientemente acerca de la infección fúngica invasiva por hongos filamentosos en el paciente crítico. Un grupo multidisciplinar compuesto por diferentes especialistas españoles con interés en este campo ha seleccionado los artículos. Cada autor ha analizado y comentado una publicación, referente a la etiología, epidemiología y diagnóstico de las micosis profundas por hongos filamentosos. Además, se valoran las estrategias de diagnóstico y tratamiento precoz de estas graves infecciones en las unidades de cuidados intensivos.
Palabras clave:
Infección fúngica invasora
UCI
Mohos
Aspergillus
EPOC
Full text is only aviable in PDF
References
[1.]
C. Alberti, C. Brun-Buisson, H. Burchardi, C. Martin, S. Goodman, A. Artigas, et al.
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.
Intensive Care Med, 28 (2002), pp. 108-121
[2.]
G. Dimopoulos, M. Piagnerelli, J. Berre, I. Salmon, J.I. Vincent.
Post mortem examination in the intensive care unit: still useful?.
Intensive Care Med, 30 (2004), pp. 2080-2085
[3.]
J.J. Janssen, R.J. Strack van Schijndel, E.H. Van der Poest Clement, G.J. Ossenkoppele, L.G. Thijs, P.C. Huijgens.
Outcome of ICU treatment in invasive aspergillosis.
Intensive Care Med, 22 (1996), pp. 1315-1322
[4.]
W. Meersseman, S.J. Vandecasteele, A. Wilmer, E. Verbeken, W.E. Peetermans, E. Van Wijngaerden.
Invasive aspergillosis in critically ill patients without malignancy.
Am J Respir Crit Care Med, 170 (2004), pp. 621-625
[5.]
J. Garnacho-Montero, R. Amaya-Villar, C. Ortiz-Leyba, C. León, F. Álvarez-Lerma, J. Nolla-Salas, et al.
Isolation Of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.
Crit Care, 9 (2005), pp. R191-R199
[6.]
E. Maravi-Poma, Jl. Rodríguez-Tudela, J.G. De Jalón, A. Manrique-Larralde, L. Torroba, J. Urtasun, et al.
Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients.
Intensive Care Med, 30 (2004), pp. 724-728
[7.]
M.D. Zilberberg, A.F. Shorr.
Fungal infections in the ICU.
Infect Dis Clin North Am, 23 (2009), pp. 625-642
[8.]
A. Mulholland, T. Casey, D. Cartwright.
Microsporum canis in a neonatal intensive care unit patient.
Australas J Dermatol, 49 (2008), pp. 25-26
[9.]
A.V. Sproul, J. Whitehall, C. Engler.
Trichophyton tonsurans - ringworm in an NICU.
Neonatal Netw, 28 (2009), pp. 305-308
[10.]
P. Samarakoon, A.O. Soubani.
Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature.
Chronic Respiratory Disease, 5 (2008), pp. 19-27
[11.]
R. Zaragoza, J. Pemán.
Diagnostic and therapeutic approaches to fungal infections in critical care settings: different options but the same strategy.
J Invasive Fungal Infect, 1 (2007), pp. 50-58
[12.]
W.W. Hope, T.J. Walsh, D.W. Denning.
Laboratory Diagnosis of invasive aspergillosis.
The Lancet Infectious Diseases, 5 (2005), pp. 609-622
[13.]
A. Cornillet, C. Camus, S. Nimubona, V. Gandemer, P. Tattevin, C. Belleguic, et al.
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Clin Infect Dis, 43 (2006), pp. 577-584
[14.]
P. Bulpa, A. Dive, Y. Sibille.
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.
Eur Respir J, 30 (2007), pp. 782-800
[15.]
J.J. Caston, M.J. Linares, C. Gallego, A. Rivero, P. Font, F. Solis, et al.
Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi.
Chest, 131 (2007), pp. 230-236
[16.]
J. Guinea, M. Torres-Narbona, P. Gijón, P. Muñoz, F. Pozo, T. Peláez, et al.
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
Clin Microbiol Infect, 16 (2010), pp. 870-877
[17.]
J. Jensen, J. Guinea, M. Torres-Narbona, P. Muñoz, T. Peláez, E. Bouza.
Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity.
J Infect, 60 (2010), pp. 162-167
[18.]
A.C. Pasqualotto, D.W. Denning.
Post-operative aspergillosis.
Clin Microbiol Infect, 12 (2006), pp. 1060-1076
[19.]
T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, K.A. Marr, et al.
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society Of America.
Clin Infect Dis, 46 (2008), pp. 327-360
[20.]
W. Meersseman, K. Lagrou, J. Maertens, A. Wilmer, G. Hermans, S. Vanderschueren, et al.
Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
Am J Respir Crit Care Med, 177 (2008), pp. 27-34
[21.]
S. Husain, D.L. Paterson, S.M. Studer, M. Crespo, J. Pilewski, M. Durkin, et al.
Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
Transplantation, 83 (2007), pp. 1330-1336
[22.]
C.J. Clancy, R.A. Jaber, H.L. Leather, J.R. Wingard, B. Staley, L.J. Wheat, et al.
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
J Clin Microbiol, 45 (2007), pp. 1759-1765
[23.]
E.J. Anaissie.
A bad bug takes on a new role as a cause of ventilator-associated pneumonia.
Am J Respir Crit Care Med, 177 (2008), pp. 1-2
[24.]
M.H. Nguyen, R. Jaber, H.L. Leather, J.R. Wingard, B. Staley, L.J. Wheat, et al.
Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
J Clin Microbiol, 45 (2007), pp. 2787-2792
[25.]
T. Saito, N. Shime, K. Itoh, N. Fujita, Y. Saito, M. Shinozaki, et al.
Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an intensive care unit: a case report.
Infection, 37 (2009), pp. 547-550
[26.]
J. Maertens, K. Theunissen, E. Verbeken, K. Lagrou, J. Verhaegen, M. Boogaerts, et al.
Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.
Br J Haematol, 126 (2004), pp. 852-860
[27.]
D. Kralt, B. Light, M. Cheang, T. Macnair, L. Wiebe, B. Limerick, et al.
Clinical characteristics and outcomes in patients with pulmonary blastomycosis.
Mycopathologia, 167 (2009), pp. 115-124
[28.]
K. Schaffer, S.F. Fitzgerald, M. Commane, A. Maguiness, L.E. Fenelon.
A pseudo-outbreak of Fusarium solani in an intensive care unit associated with bronchoscopy.
J Hosp Infect, 69 (2008), pp. 400-402
Copyright © 2011. Elsevier España S.L.. All rights reserved
